Tue, Sep 16, 2014, 3:29 AM EDT - U.S. Markets open in 6 hrs 1 mins

Recent

% | $
Quotes you view appear here for quick access.

Progenics Pharmaceuticals, Inc. Message Board

  • dr.vinmantoo dr.vinmantoo Feb 16, 2013 12:13 AM Flag

    Where is the New poster?

    PGNX stated in their press release that the poster with the phase I data would be available in the events section of their web site for 30 days. I checked several times and it isn't there yet. Can anyone find it?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • It is the first item under the Events tab

    • I don't know about the poster but I wanted to ask you something else. The FDA is worried about the effect of Relistor on the patients heart. Does heart tissue have any MU receptors ? I believe that in cases of death due to opioid overdoses the heart stops beating. Do you think there is any connection?

      • 1 Reply to trufflesdrive
      • truffles, I thought the FDA was worried about what would happen to the heart in long-term opiate users when Relistor blocked the opiates binding. That would mean there are indeed Mu-opiod receptors. Given that they are present in the smooth muscles of the digestive tract, I wouldn't be surprised that they would be found in cardiac muscle. What bothers me is that if the FDA is so worried about the effects of Relistor blocking opiate receptors of long-time opiate users, then they should ban the use of opiates long-term as one would get the same effect upon stopping opiates. If not, then have people stop using opiates for a week under doctor supervision to monitor the heart, then if all looks well then patients can resume taking opiate but adding in Relistor.

 
PGNX
5.15-0.12(-2.28%)Sep 15 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Avanir Pharmaceuticals, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT
21Vianet Group, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT
JDS Uniphase Corporation
NasdaqGSMon, Sep 15, 2014 4:15 PM EDT